The Stereotactic Surgery Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global market for stereotactic surgery devices has experienced consistent growth recently. The market size expanded from $21.8 billion in 2024 to $22.63 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 3.8%.
The Stereotactic Surgery Devices Global Market Report 2025 projects the market size to reach $28.89 billion in 2029, growing at a compound annual growth rate (CAGR) of 6.3%.
Download Your Free Sample of the 2025 Stereotactic Surgery Devices Market Report and Uncover Key Trends Now!The key drivers in the stereotactic surgery devices market are:
• Rising cases of cancer driving demand for stereotactic surgical procedures
• Integration of AI and Machine Learning in stereotactic surgery devices
• Expansion of stereotactic surgery into new medical specialty areas
• Increasing geriatric population needing specialized treatments.
The stereotactic surgery devices market covered in this report is segmented –
1) By Product: Gamma Knife, Line Accelerator (LINAC) Machines, Proton Beam, CyberKnife
2) By Application: Brain Tumor Treatment, Arteriovenous Malformations Treatment, Parkinsons Disease, Epilepsy, Other Applications
3) By End User: Hospitals, Laboratories
The key trends in the stereotactic surgery devices market are:
• The integration of artificial intelligence and machine learning is one emerging trend.
• The trend toward expanding stereotactic surgical devices into new medical specialties is emerging.
• Personalization and customization of treatments is a growing trend.
• Advancements in robotics and automation technology are emerging trends shaping the market.
The major players in the stereotactic surgery devices market are:
• Alliance Oncology
• Micromar Industria Commercio Ltda
North America was the largest region in the stereotactic surgery devices market in 2024